Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Indzi Katik"'
Autor:
Fabienne Mackay, Paul J. Hertzog, Andreas Strasser, Kirsten A. Fairfax, William A. Figgett, Pin Shie Quah, Indzi Katik, Fabien B. Vincent, Lorraine A. O'Reilly, Pali Verma, Raelene J. Grumont, Devy Deliyanti, Steve Gerondakis, Melanie Le Page
Publikováno v:
Immunity. 39(3)
SummaryActivation-induced cell death (AICD) plays a critical role in immune homeostasis and tolerance. In T-cell-dependent humoral responses, AICD of B cells is initiated by Fas ligand (FasL) on T cells, stimulating the Fas receptor on B cells. In co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e70c4b772bab5015104a8cb251ff23d
https://pubmed.ncbi.nlm.nih.gov/24012421
https://pubmed.ncbi.nlm.nih.gov/24012421
Autor:
Charley Mackenzie-Kludas, Fang-Xu Jiang, Shu-Feng Zhou, Craig Nicholls, Jun-Ping Liu, He Li, Indzi Katik
Publikováno v:
Biochemical and biophysical research communications. 389(4)
Activin is a pleiotropic cytokine with broad tissue distributions. Recent studies demonstrate that activin-A inhibits cancer cell proliferation with unknown mechanisms. In this report, we demonstrate that recombinant activin-A induces telomerase inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae286a0701171dd48e909df87c9eb3fe
https://pubmed.ncbi.nlm.nih.gov/19769941
https://pubmed.ncbi.nlm.nih.gov/19769941
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 405
Human telomerase reverse transcriptase (hTERT) represents a universal tumor-associated antigen to activate specific immune response in cancer immune therapy. Peptides derived from hTERT are presented by major histocompatibility complex (MHC) class I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::15998131118c904fc1da79fb2f7881a2
https://pubmed.ncbi.nlm.nih.gov/18369818
https://pubmed.ncbi.nlm.nih.gov/18369818
Publikováno v:
Telomerase Inhibition ISBN: 9781588296832
Human telomerase reverse transcriptase (hTERT) represents a universal tumor-associated antigen to activate specific immune response in cancer immune therapy. Peptides derived from hTERT are presented by major histocompatibility complex (MHC) class I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8ed65499e04d919df9bcec3752267c2
https://doi.org/10.1007/978-1-60327-070-0_7
https://doi.org/10.1007/978-1-60327-070-0_7
